Skip to main content
. Author manuscript; available in PMC: 2022 Apr 13.
Published in final edited form as: FASEB J. 2022 Mar;36(3):e22192. doi: 10.1096/fj.202101298R

FIGURE 3.

FIGURE 3

Klotho reduces Jmjd3 expression in myogenic cells in vitro. QPCR data showing relative expression of Jmjd3 (A), Utx (B), Ezh2 (C), and Jarid2 (D) in cultured myoblasts treated with recombinant Klotho for 48-h. *Indicates significantly different from vehicle-treated cells at p < .05 analyzed by t-test. Error bar represents SEM. N = 4 or 5 for each data set